Global Contrast Media Market Analysis Report, 2020

Dublin, March 20, 2020 (GLOBE NEWSWIRE) — The “Global Contrast Media Market, by Product Type, by Application, by Modality, by Region, Industry Analysis and Forecast, 2019 – 2025” report has been added to ResearchAndMarkets.com’s offering.Nov-2019: Guerbet came into partnership with InterSystems, a leader in information technology platform particular for Healthcare. The partnership was aimed at optimizing the combination of Contrast & Care contrast media injection management solution into the IT systems of hospitals and medical imaging centers.Sep-2019: Guerbet partnered with IBM Watson. The partnership was aimed at working on artificial intelligence software for diagnosing liver cancer.Jun-2019: Daiichi Sankyo signed an agreement with GE Healthcare. Under this agreement, Daiichi transferred the exclusive development and marketing rights in Japan for four diagnostics imaging agents to GE Healthcare. It also transferred the marketing authorization rights in Japan to GE Healthcare Pharma Limited.Jan-2018: Trivitron signed a joint venture agreement with IFHA. This joint agreement was focused on the African Continent. The joint venture company provides turn-key solutions, medical services, engineering support, etc. Both the companies have equal ownership in this JV.Acquisitions & Mergers
Oct-2019: Lantheus Holdings signed an agreement to acquire Progenics Pharmaceuticals. This acquisition brought the therapeutics and imaging agents of the latter company to Lantheus. Its portfolio is expected to complement the diagnostic capabilities of Lantheus.Oct-2017: Bracco Imaging acquired SurgVision, a real-time fluorescence image-guided surgery start-up. The acquisition helped the company in becoming the most advanced company. The portfolio of SurgVision expanded the imaging solutions of Bracco.Product Launches & Expansions
Sep-2019: Bayer launched the Medrad Stellant Flex CT injection system. This system provides individualized patient protocols and personalized imaging for capital equipment with the company’s TechCare program.Feb-2019: Bayer introduced the MEDRAD Centargo CT injection system. This is the latest addition to its range of imaging products.Jul-2018: GE released Omnipaque (iohexol) Oral Solution in the US. This is a new ready-to-drink contrast medium, which can be used to help the physicians in diagnosing medical conditions through improving the diagnostic visualization of the abdominal gastrointestinal tract.Jul-2018: GE unveiled Clariscan (gadoteric acid), a new macrocyclic MRI contrast agent in Korea. This launch expanded the company’s foothold in Korea. This is a gadolinium-based contrast agent, which has been indicated for use with MRI in the brain, spine, and associated tissue in adults. Earlier, in Mar-2017, GE launched this contrast agent in Europe.Mar-2018: Guerbet introduced OptiVantage multi-use contrast media injector in Europe. This injector was designed for injecting the contrast agents used in computed tomography (CT) scan medical examinations.Key Topics CoveredResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900